https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-06778&r=1
Lorlatinib in Combination with Ramucirumab for Treatment in Patients with Advanced ALK-rearranged Advanced Non-Small Cell Lung Cancer
lorlatinibcombinationramucirumabtreatmentpatients